<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03592277</url>
  </required_header>
  <id_info>
    <org_study_id>SF-18-42</org_study_id>
    <nct_id>NCT03592277</nct_id>
  </id_info>
  <brief_title>Vitamin C &amp; Thiamine in Sepsis</brief_title>
  <official_title>Vitamins B1 and C to Improve Outcomes in Patients With Severe Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint Francis Care</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saint Francis Care</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators propose to investigate the use of IV vitamins B1 and C in a randomized,
      double-blinded, prospective trial to determine if these medications decrease mortality rates
      in patients with severe sepsis or septic shock.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 14, 2018</start_date>
  <completion_date type="Anticipated">August 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>All parties involved, except for pharmacy personnel will be blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality Rates</measure>
    <time_frame>through study completion (average of 60 days)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>hospital length of stay</measure>
    <time_frame>through study completion (average of 60 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive Care Unit length of stay</measure>
    <time_frame>through study completion (average of 60 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>readmission rate</measure>
    <time_frame>30 day after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ventilator days</measure>
    <time_frame>through study completion (average of 60 days)</time_frame>
    <description>Number of days patient required ventilator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hours on vasopressors</measure>
    <time_frame>through study completion (average of 60 days)</time_frame>
    <description>Number of hours patient required vasopressors</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Sepsis</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Intervention Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will receive 1.5g of vitamin C in 100mL of 0.9% sodium chloride (normal saline) every six hours for four days or until discharge from the ICU, whichever happens first (seventeen dose maximum). In addition, they will receive 200 mg IV vitamin B1 every 12 hours in 50 mL of normal saline for four days or until ICU discharge (whichever happens first, nine dose maximum).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in the control arm will receive the 100 mL of 0.9% sodium chloride every six hours and 50 mL of 0.9% sodium chloride every 12 hours to act as placebos for the vitamins C and B1 respectively.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin C</intervention_name>
    <description>Patients will receive 1.5g of vitamin C in 100mL of 0.9% sodium chloride (normal saline) every six hours for four days or until discharge from the ICU, whichever happens first (seventeen dose maximum).</description>
    <arm_group_label>Intervention Arm</arm_group_label>
    <other_name>Ascorbic Acid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin B1</intervention_name>
    <description>Patients will also receive 200 mg of IV vitamin B1 every 12 hours in 50 mL of normal saline for four days or until ICU discharge (whichever happens first, nine dose maximum).</description>
    <arm_group_label>Intervention Arm</arm_group_label>
    <other_name>Thiamine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Patients must meet all inclusion criteria:

          1. Between the ages of 18 and 90 years old

          2. Have severe sepsis or septic shock. Severe sepsis and septic shock will be defined by
             the Surviving Sepsis 2012 guidelines.

          3. Weight more than 30 kg

          4. Full code

        Exclusion Criteria:

          1. Not diagnosed with severe sepsis or septic shock

          2. Younger than 18 or older than 90 years old

          3. With a history of nephrolithiasis

          4. Who are pregnant

          5. Weigh less than 30 kg

          6. Not located in the ICU

          7. Do not resuscitate (DNR) or do not intubate (DNI), no escalation of care, or comfort
             measures only (CMO)

          8. Currently on dialysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Shapiro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Francis Hospital and Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Shapiro, MD</last_name>
    <phone>860-714-5237</phone>
    <email>DShapiro@TrinityHealthOfNE.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Saint Francis Hospital and Medical Center</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David S Shapiro, MD</last_name>
      <email>DShapiro@TrinityHealthOfNE.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>June 18, 2018</study_first_submitted>
  <study_first_submitted_qc>July 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2018</study_first_posted>
  <last_update_submitted>November 21, 2019</last_update_submitted>
  <last_update_submitted_qc>November 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>Septic Shock</keyword>
  <keyword>Vitamin C</keyword>
  <keyword>Thiamine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Thiamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

